Bonjesta 20 mg / 20 mg
Bonjesta 20 mg / 20 mg is a medicine authorised by Swissmedic under authorisation number 68867. The authorisation holder is Exeltis Suisse SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 December 2023 and the authorisation is limited until 04 December 2028. ATC code R06AA59 places the medicine in the group Antihistamines for systemic use.
| Authorisation number | 68867 |
|---|---|
| Name | Bonjesta 20 mg / 20 mg |
| Full name | Bonjesta 20 mg / 20 mg, Tablette mit veränderter Wirkstofffreisetzung |
| Authorisation holder | Exeltis Suisse SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | R06AA59 |
| First authorisation | 05 December 2023 |
| Authorisation validity | 04 December 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Bonjesta 20 mg / 20 mg, Tablette mit veränderter Wirkstofffreisetzung | B | 05 December 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Tablette(n) | R06AA59 | 01.09.0. | B |
| 2 | 20 | Tablette(n) | R06AA59 | 01.09.0. | B |
| 3 | 30 | Tablette(n) | R06AA59 | 01.09.0. | B |
| 4 | 40 | Tablette(n) | R06AA59 | 01.09.0. | B |
| 5 | 50 | Tablette(n) | R06AA59 | 01.09.0. | B |
| 6 | 60 | Tablette(n) | R06AA59 | 01.09.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Bonjesta 20 mg / 20 mg authorised in Switzerland?
Yes. Bonjesta 20 mg / 20 mg is authorised by Swissmedic under authorisation number 68867, data as of 01 September 2026. The authorisation is limited until 04 December 2028.
Which dispensing category does Bonjesta 20 mg / 20 mg have?
Bonjesta 20 mg / 20 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Bonjesta 20 mg / 20 mg?
The authorisation holder is Exeltis Suisse SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.